baber/WOPTO huggingface dataset:
Patent AU-2020210821-A1 (AU)
Title: Device for providing adhesive
Inventor: SCHULTE-GÖBEL CHRISTOF
IPC: B29C48/35
Filed: 2020-01-21
Abstract: The invention relates to a device for providing adhesive (1) without an adhesive basin, comprising a conveyor unit (4), having a first conveying means, a first inlet (3) and a first outlet (6), through which an adhesive present at least in part as a solid is conveyed, and further comprising a heating unit (7), having a second inlet (9) and a second outlet (10a), and a first heating means for softening and/or liquefying the adhesive. The device finally comprises a dosing unit (14) having a dosing inlet (10b), a longitudinal slot (11) and a roller (13). In order to provide a device working efficiently and cleanly and a method for providing adhesive, a dosing unit having a dosing inlet, a longitudinal slot and a roller is provided.
Patent AU-2020217306-A1 (AU)
Title: Use of extended detection periods for range aliasing detection and mitigation in a light detection and ranging (lidar) system
Inventor: SHAND MARK ALEXANDER
IPC: G01S7/4865
Filed: 2020-08-10
Abstract: A computing system may operate a LIDAR device to emit and detect light pulses in accordance 
with a time sequence including standard detection period(s) that establish a nominal detection 
range for the LIDAR device and extended detection period(s) having durations longer than 
those of the standard detection period(s). The system may then make a determination that the 
LIDAR detected return light pulse(s) during extended detection period(s) that correspond to 
particular emitted light pulse(s). Responsively, the computing system may determine that the 
detected return light pulse(s) have detection times relative to corresponding emission times of 
particular emitted light pulse(s) that are indicative of one or more ranges. Given this, the 
computing system may make a further determination of whether or not the one or more ranges 
indicate that an object is positioned outside of the nominal detection range, and may then 
engage in object detection in accordance with the further determination.
Patent AU-2020219494-A1 (AU)
Title: Photo-protective plant-derived composition
Inventor: BEN-VALID SHOSHANA
IPC: A61Q19/00
Filed: 2020-02-06
Abstract: Described herein is a process for obtaining a UV-absorbing material, optionally 1,2,3,4,6-pentagalloyl glucose, from sumac leaves and/or budding fruits, as well as a UV-absorbing material obtained according to said process, and compositions comprising such a UV-absorbing material. The process comprises contacting sumac leaves and/or budding fruits with a water miscible organic solvent, and removing the water-miscible organic solvent. Compositions described herein sunscreen compositions wherein a concentration of the UV-absorbing material is at least 0.005 mg/ml, as well as pharmaceutical and/or cosmetic compositions.
Patent AU-2020223441-A1 (AU)
Title: Dry pharmaceutical formulations of CNP conjugates
Inventor: SKANDS ANJA R H
IPC: A61K38/27
Filed: 2020-02-10
Abstract: A dry pharmaceutical formulation, wherein the pharmaceutical formulation comprises a CNP conjugate, a buffering agent and a bulking agent and wherein the CNP conjugate comprises a CNP moiety that is covalently and reversibly conjugated to a polymeric moiety.
Patent AU-2020238572-A1 (AU)
Title: Milling and whipstock assembly with flow diversion component
Inventor: ALI MOHSEN ALIELDIN
IPC: E21B7/06
Filed: 2020-02-04
Abstract: An apparatus for performing a milling operation includes a mill having an internal fluid conduit and a fluid port configured to connect the internal fluid conduit to an exterior of the mill. A moveable flow diversion component is configured to move axially in the internal conduit from a first axial position in which fluid is prevented from flowing between the internal fluid conduit and the fluid port, to a second axial position in which the internal fluid conduit is in fluid communication with the fluid port. The apparatus also includes one or more slots configured to engage one or more pins extending into the internal fluid conduit, the one or more slots defining a path that directs movement of the flow diversion component. The flow diversion component is configured to be moved from the first to the second axial position by changing fluid pressure in the internal fluid conduit.
Patent AU-2020239700-A1 (AU)
Title: Quantitation of tamoxifen and metabolites thereof by mass spectrometry
Inventor: CLARKE NIGEL
IPC: G01N27/62
Filed: 2020-09-23
Abstract: QUANTITATION OF TAMOXIFEN AND METABOLITES THEREOF BY 
MASS SPECTROMETRY 
ABSTRACT 
Provided are methods for determining the amount of tamoxifen and its metabolites in a sample 
by mass spectrometry. In some aspects, the methods provided herein comprise determining the 
amount of norendoxifen. In some aspects, the methods provided herein comprise determining the 
amount of norendoxifen and tamoxifen. In some aspects, the methods provided herein comprise 
determining the amount of norendoxifen and other tamoxifen metabolites. In some aspects, the 
methods provided herein comprise determining the amount of tamoxifen, norendoxifen, and 
other tamoxifen metabolites.
Patent AU-2020239794-A1 (AU)
Title: Tempered vacuum glass
Inventor: ZHAO YAN
IPC: C03C27/08
Filed: 2020-09-25
Abstract: Title: TEMPERED VACUUM GLASS 
Abstract: Tempered vacuum glass, including at least two glass sheets (1) arranged parallel 
to each other. At least one of the glass sheets (1) is tempered glass. Peripheries of adjacent glass 
sheets (1) are sealed using an edge sealing body (2). Support members (3) are disposed in an 
array between the glass sheets to form a vacuum space. The edge sealing body (2) is a metallic 
edge sealing structure formed by sealing the peripheries of the adjacent glass sheets (1) with 
metal. The edge sealing body (2) is composed of a transition layer, a metallized layer, an 
intermetallic compound layer, a solder layer, an intermetallic compound layer, a metallized 
layer, and a transition layer stacked in sequence. The metallized layer is a spongy skeleton 
structure formed by sintering a metal paste. After being heated and melted, solder fills pores of 
the spongy skeleton structures on the surfaces of adjacent metallized layers to form the 
intermetallic compound layers. The tempered glass has the advantages of both tempered glass 
and vacuum glass, and the edge sealing body (2) can satisfy the requirements for edge sealing 
tightness of the vacuum glass and ensure mechanical performance, durability, and weathering 
resistance of the tempered vacuum glass.
Patent AU-2020256283-A1 (AU)
Title: Porcine circovirus type 3 (PCV3) vaccines, and production and uses thereof
Inventor: IYER ARUN
IPC: A61K39/12
Filed: 2020-04-06
Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.
Patent AU-2020257095-A1 (AU)
Title: Systems and methods for verification of income and assets
Inventor: THOMAS NICHOLAS A
IPC: G06Q20/40
Filed: 2020-10-21
Abstract: OF THE DISCLOSURE 
A method for providing an accurate evaluation of a borrower's creditworthiness includes 
using a network-connected aggregation server to aggregate records of a plurality of financial 
transactions from one or more network-connected financial institution servers, wherein each 
record of a financial transaction comprises a unique identifier associated with its transaction and 
using the records of the plurality of financial transactions to determine estimated financial 
information of the borrower. The estimated financial information of the borrower may include an 
estimated cash flow stream of the borrower, an estimated income stream of the borrower, an 
estimated trade line of the borrower, or estimated assets of the borrower. The method may also 
include using the estimated financial information of the borrower to create an evaluation of the 
borrower's creditworthiness and providing the evaluation of the borrower's creditworthiness to a 
recipient that is considering whether to extend a loan to the borrower.  
26
Patent AU-2020266117-A1 (AU)
Title: Selection of fibroblast donors for optimization of allogeneic fibroblast-mediated regeneration
Inventor: O'HEERON PETE
IPC: A61K35/33
Filed: 2020-04-27
Abstract: Embodiments of the disclosure include methods and compositions related to selecting donor fibroblasts suitable for use in an allogeneic recipient individual. The methods and compositions encompass identifying expression of one or more human leukocyte antigens (HLA) and in some cases expression of one or more other factors, including regenerative factors.
Patent AU-2020273358-A1 (AU)
Title: Suppressing/transforming leakage errors in hyperfine qubits
Inventor: HAYES DAVID
IPC: G06N10/00
Filed: 2020-11-20
Abstract: SUPPRESSING/TRANSFORMING LEAKAGE ERRORS IN HYPERFINE QUBITS 
ABSTRACT 
A quantum computer comprises an apparatus having atomic objects therein; a first manipulation 
source configured to provide a first manipulation signal; a second manipulation source 
configured to provide a second manipulation signal; and a controller. The controller is 
configured to cause the first manipulation source to provide the first manipulation signal to a 
region of the apparatus; and cause the second manipulation source to provide the second 
manipulation signal to the region. The first manipulation signal is tuned to excite atomic objects 
within the region from a leaked state outside of the qubit space to an intermediary manifold and 
to suppress excitation of atomic objects that are in the qubit space. The second manipulation 
signal is tuned to excite atomic objects from the intermediary manifold to a decay manifold from 
which there is a non-zero probability that an atomic object will decay into the qubit space.  
- 1-
H211424-AU 1/11 
100 
10 
20 
110 
CONTROLLER 
30 
40 
50 
64A 66A 
64B 66B 
64C 66C .  
FIG. 1
Patent AU-2020278407-A1 (AU)
Title: Supporting apparatus, system and method
Inventor: BREEN PAUL
IPC: E04G21/32
Filed: 2020-05-18
Abstract: A barrier support apparatus (10) is provided for supporting a barrier above a substrate (14). The apparatus has a base (16) with a base engagement zone (19) to be supported on the upper surface of the substrate, for supporting a barrier-support post (12). A lifting portion (26) is provided and has a mode of movement, which may be rotational or upwards and downwards relative to the base. A first brace (40) is provided to brace against an underside of an overhanging part of an upper portion (74) of the substrate to clamp that part between the first brace and base. A second brace fixed in relation to, and extending away from, the first brace and having a second brace (70), extends downwards from first brace and is adapted to face a wall surface (72) that extends downwards from the upper portion (74) of the substrate and that is recessed relative to the overhanging part.
Patent AU-2020339559-A1 (AU)
Title: Engineered T cells and methods of producing thereof
Inventor: FAN XIAOHU
IPC: C12N15/13
Filed: 2020-08-28
Abstract: A modified T cell comprising a functional exogenous receptor is provided. The functional exogenous receptor comprises: (a) an extracellular ligand binding domain, (b) a transmembrane domain, and (c) an intracellular signaling domain (ISD) comprising a chimeric signaling domain (CMSD), wherein the CMSD comprises a plurality of Immune-receptor Tyrosine-based Activation Motifs (ITAMs) optionally connected by one or more linkers. Further provided are vectors, methods of producing, pharmaceutical compositions, kits, and methods of treatment thereof.
Patent AU-2020341109-A1 (AU)
Title: Treatment of fragile X syndrome with ibudilast in combination with metformin, cannbidiol, sertraline or quercetin
Inventor: BROWN DAVID
IPC: A61P25/00
Filed: 2020-09-04
Abstract: The present invention relates to compositions and kits comprising (i) ibudilast, or a pharmaceutically acceptable salt thereof; and (ii) Compound A, or a pharmaceutically acceptable salt thereof, Wherein Compound A is selected from: metformin, cannabidiol, sertraline, and quercetin. The compositions and kits are useful in the treatment of Fragile X syndrome.
Patent AU-2020348675-A1 (AU)
Title: Azole-fused pyridazin-3(2H)-one derivatives
Inventor: MONENSCHEIN HOLGER
IPC: A61K31/5025
Filed: 2020-09-15
Abstract: Disclosed are compounds of Formula (1) and pharmaceutically acceptable salts thereof, wherein α, β, n, R
Patent AU-2020370127-A1 (AU)
Title: Absorbent articles and methods for manufacturing same
Inventor: ABUTO FRANCIS P
IPC: B32B7/05
Filed: 2020-10-21
Abstract: A one-ply absorbent article comprising a nonwoven first layer; a nonwoven third layer; a nonwoven second layer between the first layer and the third layer; and wherein the one-ply absorbent article has a first absorbency measure at a first delamination state and a second absorbency measure at a second delamination state, wherein the first absorbency measure is less than the second absorbency measure and the first delamination state is less than the second delamination state.
Patent AU-2020375139-A1 (AU)
Title: Method for automatically displaying measurement values
Inventor: DEGTJAREW WLADIMIR
IPC: G06T15/00
Filed: 2020-10-29
Abstract: The invention relates to a method for automatically displaying measurement values, having the steps of transmitting a number of measurement value groups detected by a sensor system, wherein each measurement value group has n variables, ascertaining an optical value range for the display of the n-th variables, transforming the values of the n-th variables of the measurement value groups into optical values from the optical value range, displaying the variables 1 to n-1 of the measurement value groups in a coordinate system with n-1 dimensions, and displaying the points of the measurement value groups in the optical values assigned to the n-th variables of the measurement value groups.
Patent AU-2020378009-A1 (AU)
Title: MrgprX2 antagonists and uses thereof
Inventor: CEVIKBAS FERDA
IPC: A61K31/506
Filed: 2020-11-05
Abstract: The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically or orally acceptable carrier for administration.
Patent AU-2020379040-A1 (AU)
Title: Gastric residence systems having a filament for improved gastric residence
Inventor: KANASTY ROSEMARY
IPC: A61K9/22
Filed: 2020-11-06
Abstract: Provided are gastric residence systems comprising: a core; a plurality of arms connected to the core at a proximal end through a plurality of linker components, one linker component of the plurality of linker components corresponding to each arm of the plurality of arms, and the plurality of arms extending radially from the proximal end, and a filament circumferentially connecting each arm of the plurality of arms.
Patent AU-2020382698-A1 (AU)
Title: End-to-end unmanned control system of aircraft navigation and surveillance systems
Inventor: FERLA MASSIMILIANO
IPC: G08G5/00
Filed: 2020-06-11
Abstract: A control system in communication with one of an aircraft navigational aid system and an aircraft surveillance system is described. The control system obtains measurement data associated with radio frequency (RF) signals transmitted by the one of the aircraft navigational aid system and the aircraft surveillance system from an unmanned aerial vehicle (UAV) reporting the measurement data. The control system also determines whether the measurement data indicates the RF signals are within a range of values based on a location of the UAV in an airspace proximate to the one of the aircraft navigational aid system and the aircraft surveillance system. The control system further controls the RF signals transmitted by the one of the aircraft navigational aid system and the aircraft surveillance system based on the measurement data and the location of the UAV. Methods performed by the control system are also described.
Patent AU-2020397401-A1 (AU)
Title: Chronic wound healing composition and application thereof
Inventor: LO HSU EN
IPC: A61K31/555
Filed: 2020-09-29
Abstract: A composition having a chronic wound healing effect, particularly diabetic wound healing; the composition is mainly composed of the following three components: (1) an anti-inflammatory agent, selected from a group consisting of acteoside, isoacteoside, and a combination thereof, (2) an astringent, selected from a group consisting of gallic acid, hypogallic acid, a salt thereof, and a combination thereof, and (3) a cooling agent, selected from a group consisting of borneol, menthol, and a combination thereof, the foregoing may be combined with one or more pharmaceutically acceptable carriers as needed. A use of the described composition in preparing a medicament for treating chronic wounds, particularly diabetic wounds.
Patent AU-2021201136-A1 (AU)
Title: Deployment constraining sheath that enables staged deployment by device section
Inventor: JOHNSON MATTHEW A
IPC: A61B17/11
Filed: 2021-02-22
Abstract: Various aspects of the present disclosure are directed toward medical devices, 
systems, and methods. The medical devices may include a portion having a radially 
expansive force greater than a radially expansive force other portions of the device.  
In addition, the medical device may include one or more constraining mechanisms for 
deployment of the medical devices.  
25 
17437827_1 (GHMatters) P111902.AU.1
5/7 
316 314 
/,1308 
310 
310 318 304 
300 
FIG. 5
Patent AU-2021201364-A1 (AU)
Title: Drill fluid and method for tunneling
Inventor: SMITH CARL KEITH
IPC: E21D9/13
Filed: 2021-03-02
Abstract: A method for drilling a tunnel through a formation must address environmental 
concerns. One tunneling method comprises the steps of: preparing a mixed 
metal-viscosified drilling fluid including bentonite, a mixed metal viscosifier and 
controlling pH to 8.5 to 9.5 to permit a reaction between the bentonite and the 
mixed metal viscosifier; adding at least one of: (i) calcium sulfate and (ii) a 
potassium salt; and pumping the drilling fluid while drilling the tunnel with the pH 
lowered to 7 - 9. The amount of mixed metal viscosifier used can be limited such 
that the weight ratio of mixed metal viscosifier to MBT reaches up to 1:30. In the 
event that there is a problematic increase in viscosity, a non-toxic anionic thinner 
can be added to the drilling fluid. One such anionic thinner is a polyacrylate.  
17466576 1 (GHMatters) P112925.AU.2
Patent AU-2021202338-A1 (AU)
Title: Gaming chip and method for manufacturing the same
Inventor: SHIGETA YASUSHI
IPC: G06K19/00
Filed: 2021-04-19
Abstract: Summary 
A new type of RFID tag (14) is provided. A gaming chip 
(10) that incorporates a sticker-type RFID tag (14) 
comprises: an enclosing member (12) having a predetermined 
shape for enclosing the RFID tag (14); a body member (11) 
that is injection-molded to encapsulate the enclosing member 
(12) with the RFID tag (14); and a gaming chip (1) for 
amusement. The enclosing member (12) consists of a first 
part (121) and a second part (122), and at least the first 
part (121) or the second part (122) has a flat surface to 
which a sticker-type RFID tag (14) can adhere, and the first 
part (121) and the second part (122) are combined to form an 
enclosing member (12), in which the sticker-type RFID tag 
(14) is covered by the first part (121) and the second part 
(122).  
27
Fig.1 1/15 
13 10
Patent AU-2021217576-A1 (AU)
Title: Microfluidic device with interface pinning reaction vessels within a flow-through chamber, kit for forming, and use of same
Inventor: GEISSLER MATTHIAS
IPC: G01N33/53
Filed: 2021-02-08
Abstract: A technique for detection of probes in a microfluidic flow-through chamber involves a plurality of interface pinning reaction vessel formed by micro- or nano-structured relief patterning of a substrate. The relief patterning increases a surface area locally, and defines a plurality of separated interface pinning reaction vessels. The marked detection protocol may be supplied on a single layer of a stacked microfluidic chip, or the chamber may constitute a whole layer. The chip may be designed to be driven mechanically, pneumatically, hydraulically, centrifugally or by capillary action. Each vessel allows for a high density of probes, an effective region for developer-type or fluorescence-based marking, and efficient readout. Suitable probe liquids can be self-limiting to fill one vessel. Suitable developer liquids avoid dye bleeding across vessels during washing.
Patent AU-2021218239-A1 (AU)
Title: Construction member
Inventor: JANG HONG SEOK
IPC: E04F13/08
Filed: 2021-08-21
Abstract: The present invention relates to a construction member, in 
which members are consecutively mounted in the vertical, 
horizontal, or both vertical and horizontal directions of the 
wall of a building, wherein the members are rectangular and 
have member insertion grooves that are horizontally formed on 
the rear surface thereof at intervals. A construction member 
according to the present invention has at least one member 
insertion groove formed on the rear surface of a member, 
thereby being easily attached and fixed to the wall or the 
floor of the building, reducing construction time and 
construction costs, and enabling an unskilled worker to 
easily perform an operation.
Patent AU-2021225035-A1 (AU)
Title: Compositions and methods for treating non-age-associated hearing impairment in a human subject
Inventor: SIMONS EMMANUEL JOHN
IPC: C07K14/47
Filed: 2021-02-19
Abstract: Provided herein are compositions that include at least two different nucleic acid vectors, where each of the at least two different vectors includes a coding sequence that encodes a different portion of an otoferlin protein, and the use of these compositions to treat hearing loss in a subject.
Patent AU-2021227523-A1 (AU)
Title: Controlling effects after 5HT2A agonists administration
Inventor: LIECHTI MATTHIAS EMANUEL
IPC: A61K31/661
Filed: 2021-01-22
Abstract: A composition for treating an individual while reducing acute effects, including effective amounts of a psychedelic drug and a duration shortening agent. A method of treating an individual with a psychedelic drug and reducing its acute duration of action, by administering a psychedelic drug to the individual, administering a duration shortening agent to the individual, and shortening and/or reducing the acute effects of the psychedelic drug. A method of stopping the acute duration of action of a psychedelic drug in an individual, by administering a duration shortening agent to the individual after the individual has taken a psychedelic drug and stopping the acute effects of the psychedelic drug.
Patent AU-2021229131-A1 (AU)
Title: Composition for delivering physiologically active ingredients into blood vessel
Inventor: WON CHEOL HEE
IPC: A61K9/14
Filed: 2021-09-06
Abstract: ] 
The composition including porous silica particles 
according to the present invention may effectively deliver 
a bioactive material to target tissues or cells in the 
5 blood stream by modifying surfaces of the particles to 
inhibit aggregation and precipitation in the blood. In 
addition to the above advantage, the embolic composition 
including porous silica particles according to the present 
invention has advantages of having specific physical 
10 properties such as biodegradability and sustained release 
thus to achieve excellent embolization effects and 
targetability toward target tumor tissues or cells, 
thereby reducing side effects.